Last Updated : December 15, 2016
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.
Cerdelga
| Brand name | Generic name | Manufacturer | Indication(s) |
| Cerdelga | Eliglustat | Genzyme Canada, a division of sanofi-aventis Canada Inc. | Gaucher disease |
| Project Number | Call for patient input | Patient input deadline | Submit patient input |
| TBC | 2016-12-15 | 2017-02-10 | Submit |
Glatiramer acetate
| Brand name | Generic name | Manufacturer | Indication(s) |
| TBD | Glatiramer acetate | Pendopharm | Multiple Sclerosis, relapsing - remitting |
| Project Number | Call for patient input | Patient input deadline | Submit patient input |
| TBC | 2016-12-15 | 2017-02-10 | Submit |
Last Updated : December 15, 2016